O-014 - Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network study
| Autor: | Bekaii-Saab, T., Ou, F., Anderson, D., Ahn, D., Boland, P., Ciombor, K., Jacobs, N., Desnoyers, R., Cleary, J., Meyers, J., Chiorean, E., Pedersen, K., Barzi, A., Sloan, J., McCune, J., Lacouture, M., Lenz, H., Grothey, A. |
|---|---|
| Zdroj: | In Annals of Oncology June 2018 29 Supplement 5:v105-v105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|